Literature DB >> 8186715

Clinical features of oculopharyngeal muscular dystrophy among Bukhara Jews.

S C Blumen1, P Nisipeanu, M Sadeh, A Asherov, F M Tomé, A D Korczyn.   

Abstract

Oculopharyngeal muscular dystrophy (OPMD), a late onset autosomal dominant myopathy, is common among the French-Canadians and the Jews from Bukhara (Uzbekistan); most clinical histologic and genetic data published until now, as well as the recently suggested diagnostic criteria, are based on studies among the former. We studied 79 patients with OPMD belonging to the newly described Jewish-Bukhara cluster. The disease began between the ages of 21 and 78 yr (median 53 yr). In 11 patients (15%) it began before the age of 40. Ptosis was the first symptom in 59 patients and dysphagia in the remaining 20. Eight patients (10%) were monosymptomatic (ptosis) after more than 7 yr from the start of the disease; however, other family members had additional signs/symptoms. The patients belong to 29 families; in 26 age-dependent autosomal dominant inheritance could be documented. Among them there is certain evidence for genetic anticipation. This clinical study is the largest published concerning patients other than French-Canadians.

Entities:  

Mesh:

Year:  1993        PMID: 8186715     DOI: 10.1016/0960-8966(93)90119-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  9 in total

1.  Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy.

Authors:  Raffaele Dubbioso; Pasquale Moretta; Fiore Manganelli; Chiara Fiorillo; Rosa Iodice; Luigi Trojano; Lucio Santoro
Journal:  J Neurol       Date:  2011-09-29       Impact factor: 4.849

Review 2.  Exploring the Potential of Small Molecule-Based Therapeutic Approaches for Targeting Trinucleotide Repeat Disorders.

Authors:  Arun Kumar Verma; Eshan Khan; Sonali R Bhagwat; Amit Kumar
Journal:  Mol Neurobiol       Date:  2019-08-09       Impact factor: 5.590

3.  Hip flexion weakness is associated with impaired mobility in oculopharyngeal muscular dystrophy: a retrospective study with implications for trial design.

Authors:  Sarah Youssof; Ronald Schrader; David Bear; Leslie Morrison
Journal:  Neuromuscul Disord       Date:  2014-11-20       Impact factor: 4.296

4.  Oculopharyngeal muscular dystrophy as a rare differential diagnosis for unexplained dysphagia: a case report.

Authors:  Klaus Bumm; Martin Zenker; Alessandro Bozzato
Journal:  Cases J       Date:  2009-01-28

5.  Dysphagia-related quality of life in oculopharyngeal muscular dystrophy: Psychometric properties of the SWAL-QOL instrument.

Authors:  Sarah Youssof; Carol Romero-Clark; Teddy Warner; Emily Plowman
Journal:  Muscle Nerve       Date:  2017-02-12       Impact factor: 3.217

6.  The NIH Office of Rare Diseases Research patient registry Standard: a report from the University of New Mexico's Oculopharyngeal Muscular Dystrophy Patient Registry.

Authors:  Shamsi Daneshvari; Sarah Youssof; Philip J Kroth
Journal:  AMIA Annu Symp Proc       Date:  2013-11-16

7.  The relationship between physical symptoms and health-related quality of life in oculopharyngeal muscular dystrophy.

Authors:  Sarah Youssof
Journal:  Muscle Nerve       Date:  2016-03-01       Impact factor: 3.217

8.  Cross-cultural adaptation of the SWAL-QOL and the Sydney Swallow Questionnaire (SSQ) into French-Canadian and preliminary assessment for their use in an oculopharyngeal muscular dystrophy (OPMD) population.

Authors:  Claudia Côté; Julie Fortin; Bernard Brais; Sarah Youssof; Cynthia Gagnon
Journal:  Qual Life Res       Date:  2021-07-22       Impact factor: 4.147

Review 9.  Recent Progress in Oculopharyngeal Muscular Dystrophy.

Authors:  Satoshi Yamashita
Journal:  J Clin Med       Date:  2021-03-29       Impact factor: 4.241

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.